United States Atopic Dermatitis Treatment Market Report 2017

January 2017 | 122 pages | ID: U328ADF16C8EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Atopic Dermatitis Treatment

Revenue, means the sales value of Atopic Dermatitis Treatment

This report studies sales (consumption) of Atopic Dermatitis Treatment in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Sanofi
• Regeneron Pharmaceuticals
• Astellas Pharma
• Anacor Pharmaceuticals
• Meda AB
• GlaxoSmithKline
• AstraZeneca
• Pfizer

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Infancy Type
• Childhood Type
• Youth and Adulthood Type

Split by applications, this report focuses on sales, market share and growth rate of Atopic Dermatitis Treatment in each application, can be divided into

• Hospital
• Clinic
• Home

Contents

United States Atopic Dermatitis Treatment Market Report 2017

1 ATOPIC DERMATITIS TREATMENT OVERVIEW

1.1 Product Overview and Scope of Atopic Dermatitis Treatment
1.2 Classification of Atopic Dermatitis Treatment
  1.2.1 Infancy Type
  1.2.2 Childhood Type
  1.2.3 Youth and Adulthood Type
1.3 Application of Atopic Dermatitis Treatment
  1.3.1 Hospital
  1.3.2 Clinic
  1.3.3 Home
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Atopic Dermatitis Treatment (2012-2022)
  1.4.1 United States Atopic Dermatitis Treatment Sales and Growth Rate (2012-2022)
  1.4.2 United States Atopic Dermatitis Treatment Revenue and Growth Rate (2012-2022)

2 UNITED STATES ATOPIC DERMATITIS TREATMENT COMPETITION BY MANUFACTURERS

2.1 United States Atopic Dermatitis Treatment Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Atopic Dermatitis Treatment Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Atopic Dermatitis Treatment Average Price by Manufactures (2015 and 2016)
2.4 Atopic Dermatitis Treatment Market Competitive Situation and Trends
  2.4.1 Atopic Dermatitis Treatment Market Concentration Rate
  2.4.2 Atopic Dermatitis Treatment Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ATOPIC DERMATITIS TREATMENT SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Atopic Dermatitis Treatment Sales and Market Share by States (2012-2017)
3.2 United States Atopic Dermatitis Treatment Revenue and Market Share by States (2012-2017)
3.3 United States Atopic Dermatitis Treatment Price by States (2012-2017)

4 UNITED STATES ATOPIC DERMATITIS TREATMENT SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Atopic Dermatitis Treatment Sales and Market Share by Type (2012-2017)
4.2 United States Atopic Dermatitis Treatment Revenue and Market Share by Type (2012-2017)
4.3 United States Atopic Dermatitis Treatment Price by Type (2012-2017)
4.4 United States Atopic Dermatitis Treatment Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ATOPIC DERMATITIS TREATMENT SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Atopic Dermatitis Treatment Sales and Market Share by Application (2012-2017)
5.2 United States Atopic Dermatitis Treatment Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ATOPIC DERMATITIS TREATMENT MANUFACTURERS PROFILES/ANALYSIS

6.1 Sanofi
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Atopic Dermatitis Treatment Product Type, Application and Specification
    6.1.2.1 Infancy Type
    6.1.2.2 Childhood Type
  6.1.3 Sanofi Atopic Dermatitis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Regeneron Pharmaceuticals
  6.2.2 Atopic Dermatitis Treatment Product Type, Application and Specification
    6.2.2.1 Infancy Type
    6.2.2.2 Childhood Type
  6.2.3 Regeneron Pharmaceuticals Atopic Dermatitis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Astellas Pharma
  6.3.2 Atopic Dermatitis Treatment Product Type, Application and Specification
    6.3.2.1 Infancy Type
    6.3.2.2 Childhood Type
  6.3.3 Astellas Pharma Atopic Dermatitis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Anacor Pharmaceuticals
  6.4.2 Atopic Dermatitis Treatment Product Type, Application and Specification
    6.4.2.1 Infancy Type
    6.4.2.2 Childhood Type
  6.4.3 Anacor Pharmaceuticals Atopic Dermatitis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Meda AB
  6.5.2 Atopic Dermatitis Treatment Product Type, Application and Specification
    6.5.2.1 Infancy Type
    6.5.2.2 Childhood Type
  6.5.3 Meda AB Atopic Dermatitis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 GlaxoSmithKline
  6.6.2 Atopic Dermatitis Treatment Product Type, Application and Specification
    6.6.2.1 Infancy Type
    6.6.2.2 Childhood Type
  6.6.3 GlaxoSmithKline Atopic Dermatitis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 AstraZeneca
  6.7.2 Atopic Dermatitis Treatment Product Type, Application and Specification
    6.7.2.1 Infancy Type
    6.7.2.2 Childhood Type
  6.7.3 AstraZeneca Atopic Dermatitis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Pfizer
  6.8.2 Atopic Dermatitis Treatment Product Type, Application and Specification
    6.8.2.1 Infancy Type
    6.8.2.2 Childhood Type
  6.8.3 Pfizer Atopic Dermatitis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 ATOPIC DERMATITIS TREATMENT MANUFACTURING COST ANALYSIS

7.1 Atopic Dermatitis Treatment Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Atopic Dermatitis Treatment

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Atopic Dermatitis Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Atopic Dermatitis Treatment Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ATOPIC DERMATITIS TREATMENT MARKET FORECAST (2017-2022)

11.1 United States Atopic Dermatitis Treatment Sales, Revenue Forecast (2017-2022)
11.2 United States Atopic Dermatitis Treatment Sales Forecast by Type (2017-2022)
11.3 United States Atopic Dermatitis Treatment Sales Forecast by Application (2017-2022)
11.4 Atopic Dermatitis Treatment Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Atopic Dermatitis Treatment
Table Classification of Atopic Dermatitis Treatment
Figure United States Sales Market Share of Atopic Dermatitis Treatment by Type in 2015
Figure Infancy Type Picture
Figure Childhood Type Picture
Figure Youth and Adulthood Type Picture
Table Application of Atopic Dermatitis Treatment
Figure United States Sales Market Share of Atopic Dermatitis Treatment by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure Home Examples
Figure United States Atopic Dermatitis Treatment Sales and Growth Rate (2012-2022)
Figure United States Atopic Dermatitis Treatment Revenue and Growth Rate (2012-2022)
Table United States Atopic Dermatitis Treatment Sales of Key Manufacturers (2015 and 2016)
Table United States Atopic Dermatitis Treatment Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Atopic Dermatitis Treatment Sales Share by Manufacturers
Figure 2016 Atopic Dermatitis Treatment Sales Share by Manufacturers
Table United States Atopic Dermatitis Treatment Revenue by Manufacturers (2015 and 2016)
Table United States Atopic Dermatitis Treatment Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Atopic Dermatitis Treatment Revenue Share by Manufacturers
Table 2016 United States Atopic Dermatitis Treatment Revenue Share by Manufacturers
Table United States Market Atopic Dermatitis Treatment Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Atopic Dermatitis Treatment Average Price of Key Manufacturers in 2015
Figure Atopic Dermatitis Treatment Market Share of Top 3 Manufacturers
Figure Atopic Dermatitis Treatment Market Share of Top 5 Manufacturers
Table United States Atopic Dermatitis Treatment Sales by States (2012-2017)
Table United States Atopic Dermatitis Treatment Sales Share by States (2012-2017)
Figure United States Atopic Dermatitis Treatment Sales Market Share by States in 2015
Table United States Atopic Dermatitis Treatment Revenue and Market Share by States (2012-2017)
Table United States Atopic Dermatitis Treatment Revenue Share by States (2012-2017)
Figure Revenue Market Share of Atopic Dermatitis Treatment by States (2012-2017)
Table United States Atopic Dermatitis Treatment Price by States (2012-2017)
Table United States Atopic Dermatitis Treatment Sales by Type (2012-2017)
Table United States Atopic Dermatitis Treatment Sales Share by Type (2012-2017)
Figure United States Atopic Dermatitis Treatment Sales Market Share by Type in 2015
Table United States Atopic Dermatitis Treatment Revenue and Market Share by Type (2012-2017)
Table United States Atopic Dermatitis Treatment Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Atopic Dermatitis Treatment by Type (2012-2017)
Table United States Atopic Dermatitis Treatment Price by Type (2012-2017)
Figure United States Atopic Dermatitis Treatment Sales Growth Rate by Type (2012-2017)
Table United States Atopic Dermatitis Treatment Sales by Application (2012-2017)
Table United States Atopic Dermatitis Treatment Sales Market Share by Application (2012-2017)
Figure United States Atopic Dermatitis Treatment Sales Market Share by Application in 2015
Table United States Atopic Dermatitis Treatment Sales Growth Rate by Application (2012-2017)
Figure United States Atopic Dermatitis Treatment Sales Growth Rate by Application (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Atopic Dermatitis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi Atopic Dermatitis Treatment Sales Market Share (2012-2017)
Table Regeneron Pharmaceuticals Basic Information List
Table Regeneron Pharmaceuticals Atopic Dermatitis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Table Regeneron Pharmaceuticals Atopic Dermatitis Treatment Sales Market Share (2012-2017)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Atopic Dermatitis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Table Astellas Pharma Atopic Dermatitis Treatment Sales Market Share (2012-2017)
Table Anacor Pharmaceuticals Basic Information List
Table Anacor Pharmaceuticals Atopic Dermatitis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Table Anacor Pharmaceuticals Atopic Dermatitis Treatment Sales Market Share (2012-2017)
Table Meda AB Basic Information List
Table Meda AB Atopic Dermatitis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Table Meda AB Atopic Dermatitis Treatment Sales Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Atopic Dermatitis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Atopic Dermatitis Treatment Sales Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Atopic Dermatitis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Atopic Dermatitis Treatment Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Atopic Dermatitis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Atopic Dermatitis Treatment Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Atopic Dermatitis Treatment
Figure Manufacturing Process Analysis of Atopic Dermatitis Treatment
Figure Atopic Dermatitis Treatment Industrial Chain Analysis
Table Raw Materials Sources of Atopic Dermatitis Treatment Major Manufacturers in 2015
Table Major Buyers of Atopic Dermatitis Treatment
Table Distributors/Traders List
Figure United States Atopic Dermatitis Treatment Production and Growth Rate Forecast (2017-2022)
Figure United States Atopic Dermatitis Treatment Revenue and Growth Rate Forecast (2017-2022)
Table United States Atopic Dermatitis Treatment Production Forecast by Type (2017-2022)
Table United States Atopic Dermatitis Treatment Consumption Forecast by Application (2017-2022)
Table United States Atopic Dermatitis Treatment Sales Forecast by States (2017-2022)
Table United States Atopic Dermatitis Treatment Sales Share Forecast by States (2017-2022)